Used as a key chiral intermediate in the synthesis of protease inhibitors, particularly in the development of antiviral drugs. Its stereochemistry enables selective binding to enzyme active sites, enhancing drug efficacy. Commonly employed in the preparation of HCV (hepatitis C virus) NS3/4A protease inhibitors due to its ability to mimic peptide motifs and resist metabolic degradation. The fluorine and nitro groups facilitate structural optimization for improved pharmacokinetics and target affinity.